gip glp 1 drugs GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 rec agonists have evolved

Presented for research literature review only Hu C et al

Weight Loss Reduces Knee-Joint Loads in Overweight and Obese Older Adults With Knee Osteoarthritis. Arthritis & Rheumatism

MoghettiPBacchiEBranganiCDonSNegriC

Clients who stop treatment often experience some weight regain, highlighting the importance of a comprehensive, long-term approach to weight management

Quantification of 2HG enantiomers 2HG quantification in SCD erythroblasts was performed as we previously described 24 by liquid chromatographymass spectrometry (LC-MS/MS) after derivatization using N-(p-Toluenesulfonyl)-L-phenylalanyl Chloride (TSPC) on the LC-ESI-MS/MS system

Data were analyzed with R software version 4.3.1 (R project for statistical computing, Vienna, Austria) and IBM SPSS version 23